CIK 0001722482 · Large accelerated filer
Avantor, Inc.
Sign in to watch- Ticker
- AVTR
- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822758923
- Phone
- (610) 386-1700
- Business address
- RADNOR CORPORATE CENTER, BUILDING ONE, SUITE 200, 100 MATSONFORD ROAD, RADNOR, PA, 19087
- Former names
- Vail Holdco Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-25 | Miller Justin EVP & General Counsel | Grant or award | +8,140 | 121,574 | ||
| 2021-02-25 | Miller Justin EVP & General Counsel | Grant or award · Stock Options (Right to Buy) | +26,347 | 26,347 | ||
| 2021-02-25 | Wondrasch Michael EVP & CIO | Grant or award | +8,140 | 148,474 | ||
| 2021-02-25 | Wondrasch Michael EVP & CIO | Grant or award · Stock Options (Right to Buy) | +26,347 | 26,347 | ||
| 2021-02-25 | Vanderhaegen Frederic EVP, Europe | Grant or award | +16,281 | 253,669 | ||
| 2021-02-25 | Vanderhaegen Frederic EVP, Europe | Grant or award · Stock Options (Right to Buy) | +52,693 | 52,693 | ||
| 2021-02-25 | Murray Mark Christopher EVP, Biomaterials & AT | Grant or award | +8,140 | 19,598 | ||
| 2021-02-25 | Murray Mark Christopher EVP, Biomaterials & AT | Grant or award · Stock Options (Right to Buy) | +26,347 | 26,347 | ||
| 2021-02-25 | Brophy Gerard EVP, Biopharma Production | Grant or award | +16,281 | 188,665 | ||
| 2021-02-25 | Brophy Gerard EVP, Biopharma Production | Grant or award · Stock Options (Right to Buy) | +52,693 | 52,693 | ||
| 2021-02-24 | Eck Steven W SVP & Chief Accounting Officer | Option exercise | +8,550 | 28,532 | ||
| 2021-02-24 | Eck Steven W SVP & Chief Accounting Officer | Shares withheld for taxes | −2,577 | $27.94 | $72K | 25,955 |
| 2021-02-24 | Brophy Gerard EVP, Biopharma Production | Sale | −3,059 | $27.93 | $85K | 172,384 |
| 2021-02-22 | Brophy Gerard EVP, Biopharma Production | Shares withheld for taxes | −3,072 | $28.69 | $88K | 175,443 |
| 2021-02-22 | Brophy Gerard EVP, Biopharma Production | Option exercise | +19,769 | $17.67 | $349K | 195,212 |
| 2021-02-22 | Brophy Gerard EVP, Biopharma Production | Sale | −19,769 | $28.62 | $566K | 175,443 |
| 2021-02-22 | Brophy Gerard EVP, Biopharma Production | Option exercise · Stock Options (Right to Buy) | −19,769 | 59,306 | ||
| 2021-02-22 | Couturier Christophe EVP, Services | Shares withheld for taxes | −1,313 | $28.69 | $38K | 162,408 |
| 2021-02-22 | Wondrasch Michael EVP & CIO | Shares withheld for taxes | −1,209 | $28.69 | $35K | 140,334 |
| 2021-02-22 | Miller Justin EVP & General Counsel | Shares withheld for taxes | −1,350 | $28.69 | $39K | 113,434 |
Page 27 of 44 · 874 trades